1. Home
  2. WBS vs RGEN Comparison

WBS vs RGEN Comparison

Compare WBS & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WBS
  • RGEN
  • Stock Information
  • Founded
  • WBS 1935
  • RGEN 1981
  • Country
  • WBS United States
  • RGEN United States
  • Employees
  • WBS N/A
  • RGEN N/A
  • Industry
  • WBS Major Banks
  • RGEN Medical/Dental Instruments
  • Sector
  • WBS Finance
  • RGEN Health Care
  • Exchange
  • WBS Nasdaq
  • RGEN Nasdaq
  • Market Cap
  • WBS 10.8B
  • RGEN 9.1B
  • IPO Year
  • WBS N/A
  • RGEN N/A
  • Fundamental
  • Price
  • WBS $55.80
  • RGEN $158.99
  • Analyst Decision
  • WBS Buy
  • RGEN Buy
  • Analyst Count
  • WBS 14
  • RGEN 11
  • Target Price
  • WBS $61.29
  • RGEN $180.63
  • AVG Volume (30 Days)
  • WBS 761.8K
  • RGEN 627.3K
  • Earning Date
  • WBS 01-17-2025
  • RGEN 02-20-2025
  • Dividend Yield
  • WBS 2.87%
  • RGEN N/A
  • EPS Growth
  • WBS N/A
  • RGEN N/A
  • EPS
  • WBS 4.37
  • RGEN N/A
  • Revenue
  • WBS $2,368,286,000.00
  • RGEN $634,439,000.00
  • Revenue This Year
  • WBS N/A
  • RGEN $2.28
  • Revenue Next Year
  • WBS $6.29
  • RGEN $9.69
  • P/E Ratio
  • WBS $12.75
  • RGEN N/A
  • Revenue Growth
  • WBS N/A
  • RGEN 0.33
  • 52 Week Low
  • WBS $39.34
  • RGEN $113.50
  • 52 Week High
  • WBS $63.99
  • RGEN $203.13
  • Technical
  • Relative Strength Index (RSI)
  • WBS 35.57
  • RGEN 53.41
  • Support Level
  • WBS $58.31
  • RGEN $143.83
  • Resistance Level
  • WBS $59.83
  • RGEN $169.00
  • Average True Range (ATR)
  • WBS 1.40
  • RGEN 5.95
  • MACD
  • WBS -0.47
  • RGEN -0.24
  • Stochastic Oscillator
  • WBS 4.72
  • RGEN 61.46

About WBS Webster Financial Corporation

Webster Financial Corp is a full-service provider of financial services, offering commercial and consumer banking, mortgages, and investment advisory along with trust and wealth management services in Connecticut, New York, Rhode Island, Massachusetts, and Pennsylvania. The company's segment includes Commercial Banking, HSA Bank, and Consumer Banking. It generates maximum revenue from the Commercial Banking segment.

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 54% of 2023 revenue, while chromatography, proteins, and process analytics were 20%, 16%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

Share on Social Networks: